Live Breaking News & Updates on Idorsia Japan

Stay updated with breaking news from Idorsia japan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Idorsia Pharmaceuticals Ltd: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million

Idorsia Pharmaceuticals Ltd: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , New Zealand , Republic Of , South Korea , Switzerland General , City Of , Neurocrine Biosciences , Andrewc Weiss , Sosei Heptares , Jean Paul Clozel , Asia Pacific , Genentech Roche , Satoshi Tanaka , Chris Cargill , Tokyo Stock Exchange , Swiss Exchange , Sosei Group Corporation , Sosei Group , Head Of Investor Relations Corporate Communications , Idorsia Pharmaceuticals Ltd , Idorsia Ltd , Sosei Heptares , Paul Clozel , Chief Executive Officer , Idorsia Japan , Vice President ,